Search filters

List of works by Koichiro Yoneyama

A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A.

scientific article published on 6 December 2017

A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?

scientific article published on 10 January 2014

A first-in-human phase 1 study of ACE910, a novel factor VIII-mimetic bispecific antibody, in healthy subjects.

scientific article

A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

scientific article published on 12 September 2019

Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

scientific article

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors

scientific article published on 27 September 2017

Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers

scientific article published on 19 September 2018

Paulina is supported by:

About Paulina

Help